Effect of in vivo administration of anti-CLTA-4 mAb and stimulatory anti-CD40 mAb on the induction of low dose oral tolerance

被引：0
|
作者：
Burns, R [1 ]
Rappold, K [1 ]
机构：
[1] Thomas More Coll, Crestview Hills, KY 41017 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A949 / A949
页数：1
相关论文
共 50 条
  • [21] Anti-CD45RO/RB mAb a new tool for tolerance induction
    Gregori, S
    Mangia, P
    Bacchetta, R
    Aversa, G
    Bottazzoli, F
    Carballido, J
    Carballido, J
    Traversari, C
    Korthaeuer, U
    Roncarolo, MG
    FASEB JOURNAL, 2003, 17 (07): : C63 - C63
  • [22] Enhanced T-cell-independent Antitumor Effect of Cyclophosphamide Combined With Anti-CD40 mAb and CpG in Mice
    Johnson, Erik E.
    Buhtoiarov, Ilia N.
    Baldeshwiler, Mark J.
    Felder, Mildred A. R.
    Van Rooijen, Nico
    Sondel, Paul M.
    Rakhmilevich, Alexander L.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (01) : 76 - 84
  • [23] Immunosuppression With Anti-CD40 mAb and Rapamycin for Islet and Kidney Co-Transplantation in Nonhuman Primates
    Oura, T.
    Hotta, K.
    Lei, J.
    Markmann, J.
    Dehnadi, A.
    Benichou, G.
    Cosimi, B.
    Kawai, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [24] THE ANTI-CD40 MAB ISCALIMAB (CFZ533) DOES NOT IMPAIR IMMUNE EBV CONTROL
    Rubic-Schneider, Tina
    Garcia, Deborah
    Marchant, Martine
    Christen, Brigitte
    Runser-Loll, Nathalie
    Rush, James
    Traggiai, Elisabetta
    Ulrich, Peter
    TRANSPLANT INTERNATIONAL, 2019, 32 : 138 - 138
  • [25] Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance
    Barone, KS
    Herms, B
    Karlosky, L
    Murray, S
    Qualls, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (02): : 196 - 203
  • [26] Combination of Adoptive Cell Transfer and Antibody Injection Can Eradicate Established Tumors in Mice-An in vivo study using anti-OX40mAb, anti-CD25mAb and anti-CTLA4mAb-
    Watanabe, Akira
    Hara, Masaki
    Chosa, Eiichi
    Nakamura, Kunihide
    Sekiya, Ryo
    Shimizu, Tetsuya
    Onitsuka, Toshio
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2010, 32 (02) : 238 - 245
  • [27] INDUCTION OF B-CELL AND T-CELL TOLERANCE IN-VIVO BY ANTI-CD23 MAB
    MORRIS, SC
    LEES, A
    HOLMES, JM
    JEFFRIES, RDA
    FINKELMAN, FD
    JOURNAL OF IMMUNOLOGY, 1994, 152 (08): : 3768 - 3776
  • [28] Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb
    Morio, T
    Hanissian, SH
    Bacharier, LB
    Teraoka, H
    Nonoyama, S
    Seki, M
    Kondo, J
    Nakano, H
    Lee, SK
    Geha, RS
    Yata, J
    IMMUNITY, 1999, 11 (03) : 339 - 348
  • [29] Effect of high dose anti-CD40 on B cell haematopoiesis
    Newton, S.
    Carlring, J. U.
    Heath, A. W.
    IMMUNOLOGY, 2010, 131 : 170 - 170
  • [30] In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
    Murillo, Oihana
    Dubrot, Juan
    Palazon, Asis
    Arina, Ainhoa
    Azpilikueta, Arantza
    Alfaro, Carlos
    Solano, Sarai
    Ochoa, Maria C.
    Berasain, Carmen
    Gabari, Izaskun
    Perez-Gracia, Jose L.
    Berraondo, Pedro
    Hervas-Stubbs, Sandra
    Melero, Ignacio
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (09) : 2424 - 2436
12345